文献速递创伤与烧伤心脑血管急症

重型创伤性脑损伤与独特凝血病表型相关

Severe traumatic brain injury is associated with a unique coagulopathy phenotype.
PubMed 文献 · J Trauma Acute Care Surg · 2019-01-01
一句话结论严重孤立性TBI与延迟凝血块形成(ACT延长、角度降低、纤维蛋白原降低)独立相关,但不伴纤溶异常,作者认为早期凝血因子替代可能优于经验性抗纤溶治疗。

本研究基于前瞻性创伤激活方案研究数据,纳入572例患者(48例孤立性重型TBI、45例重型TBI合并躯干/四肢伤、479例孤立性躯干/四肢伤),用到达时血栓弹力图评估凝血病。校正混杂因素后,与孤立性躯干/四肢伤相比,严重孤立性TBI独立关联于ACT<128秒(RR 1.5,95%CI 1.1-2.2)、角度<65度(RR 2.2,95%CI 1.4-3.6)、FFLEV<356(RR 1.7,95%CI 1.2-2.4),但与MA<55 mm、纤溶亢进、纤溶关闭或PTT>30无显著关联。作者结论认为严重孤立性TBI与独特凝血病相关,表现为凝血块形成延迟但无纤溶异常;低纤维蛋白原和ACT延长提示早期凝血因子替代可能适用于孤立性TBI患者,而非经验性抗纤溶治疗。

要点

  • 严重孤立性TBI患者到达时血栓弹力图可表现为ACT<128秒(RR 1.5,95%CI 1.1-2.2)、角度<65度(RR 2.2,95%CI 1.4-3.6)、FFLEV<356(RR 1.7,95%CI 1.2-2.4),提示凝血块形成延迟。
  • 严重孤立性TBI与纤溶亢进、纤溶关闭、MA<55 mm或PTT>30无独立关联,纤溶指标30分钟裂解百分比组间无差异。
  • 作者认为,孤立性TBI相关的低纤维蛋白原和ACT延长提示早期凝血因子替代可能优于经验性抗纤溶治疗。
  • 该研究为回顾性队列研究,证据等级为预后性III级。

适用人群与场景

  • 纳入创伤激活方案研究中的创伤患者,分为孤立性重型TBI(48例)、重型TBI合并躯干和四肢伤(45例)、孤立性躯干和四肢伤(479例)三组。
  • 场景为急诊到达时采血行血栓弹力图检测。

诊断标准与关键阈值

  • 严重孤立性TBI的凝血病表型依据到达时血栓弹力图指标:ACT<128秒、角度<65度、FFLEV<356。
  • MA<55 mm、纤溶亢进、纤溶关闭、PTT>30与严重孤立性TBI无独立关联。

研究设计与关键结果

  • 研究类型为回顾性队列研究(预后性,证据等级III级),数据来自前瞻性创伤激活方案研究,共纳入572例患者:孤立性重型TBI 48例、重型TBI合并躯干/四肢伤45例、孤立性躯干/四肢伤479例。
  • 三组间INR、ACT、角度、MA、FFLEV存在差异,但30分钟裂解百分比无差异。
  • 校正混杂因素后,与孤立性躯干/四肢伤相比,严重孤立性TBI独立关联于ACT<128秒(RR 1.5,95%CI 1.1-2.2)、角度<65度(RR 2.2,95%CI 1.4-3.6)、FFLEV<356(RR 1.7,95%CI 1.2-2.4);与MA<55 mm、纤溶亢进、纤溶关闭、PTT>30无独立关联。

证据类型、等级与局限

  • 证据类型:回顾性队列研究,预后性,证据等级III级。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对严重孤立性TBI患者,到达时血栓弹力图可能显示ACT延长、角度降低、纤维蛋白原降低,提示凝血块形成延迟,应关注凝血因子替代需求。
  • 作者认为,孤立性TBI相关的低纤维蛋白原和ACT延长提示早期凝血因子替代可能优于经验性抗纤溶治疗。
  • 严重孤立性TBI未显示与纤溶亢进或纤溶关闭独立相关,作者认为其凝血病机制独特,需进一步研究。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Traumatic brain injury (TBI) patients present on a spectrum from hypocoagulability to hypercoagulability, depending on the injury complexity, severity, and time since injury. Prior studies have found a unique coagulopathy associated with TBI using conventional coagulation assays such as INR; however, few studies have assessed the association of TBI and coagulopathy using viscoelastic assays that comprehensively evaluate the coagulation in whole blood. This study aims to reevaluate the TBI-specific trauma-induced coagulopathy using arrival thrombelastography. Because brain tissue is high in key procoagulant molecules, we hypothesize that isolated TBI is associated with procoagulant and hypofibrinolytic profiles compared with injuries of the torso, extremities, and polytrauma, including TBI.

METHODS: Data are from the prospective Trauma Activation Protocol study. Activated clotting time (ACT), angle, maximum amplitude (MA), 30-minute percent lysis after MA (LY30), and functional fibrinogen levels (FFLEV) were recorded. Patients were categorized into isolated severe TBI (I-TBI), severe TBI with torso and extremity injuries (TBI + TORSO/EXTREMITIES), and isolated torso and extremity injuries (I-TORSO/EXTREMITIES). Poisson regression was used to adjust for multiple confounders.

RESULTS: Overall, 572 patients (48 I-TBI, 45 TBI + TORSO/EXTREMITIES, 479 I-TORSO/EXTREMITIES) were included in this analysis. The groups differed in INR, ACT, angle, MA, and FFLEV but not in 30-minute percent lysis. When compared with I-Torso/Extremities, after adjustment for confounders, severe I-TBI was independently associated with ACT less than 128 seconds (relative risk [RR], 1.5; 95% confidence interval [CI], 1.1-2.2), angle less than 65 degrees (RR, 2.2; 95% CI, 1.4-3.6), FFLEV less than 356 (RR, 1.7; 95% CI, 1.2-2.4) but not MA less than 55 mm, hyperfibrinolysis, fibrinolysis shutdown, or partial thromboplastin time (PTT) greater than 30.

CONCLUSION: Severe I-TBI was independently associated with a distinct coagulopathy with delayed clot formation but did not appear to be associated with fibrinolysis abnormalities. Low fibrinogen and longer ACT values associated with I-TBI suggest that early coagulation factor replacement may be indicated in I-TBI patients over empiric antifibrinolytic therapy. Mechanisms triggering coagulopathy in TBI are unique and warrant further investigation.

LEVEL OF EVIDENCE: Retrospective cohort study, prognostic, level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Samuels JM, Moore EE, Silliman CC, et al. Severe traumatic brain injury is associated with a unique coagulopathy phenotype. J Trauma Acute Care Surg. 2019. PMID: 30601456. doi:10.1097/TA.0000000000002173

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。